Holen Sie sich die Stockscreener-App
14.94
3.03%
0.44
Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten
Can technical indicators confirm Bausch + Lomb Corporation’s reversalQuarterly Earnings Report & Technical Entry and Exit Alerts - Newser
Centuri Holdings, Inc. shares fall 1.39% intraday as Bausch + Lomb Corp terminates agreement with Carl Icahn. - AInvest
Is it time to cut losses on Bausch + Lomb Corporation2025 Key Lessons & Safe Entry Trade Signal Reports - Newser
Bausch + Lomb Announces Board ChangesAugust 18, 2025 - BioSpace
Icahn representations resign Bausch + Lomb board after agreement termination - Reuters
Bausch + Lomb Corp terminates agreement with Carl Icahn - MarketScreener
Bausch + Lomb board members resign after Icahn agreement ends By Reuters - Investing.com
Bausch + Lomb board members resign after Icahn agreement ends - Reuters
Icahn representatives resign from Bausch + Lomb board as agreement ends - Investing.com
Icahn Group Exits Bausch Boards As Paulson Steps In - Finimize
Reviewing Bausch + Lomb (NYSE:BLCO) & Co-Diagnostics (NASDAQ:CODX) - Defense World
How to build a custom watchlist for Bausch + Lomb CorporationJuly 2025 Patterns & Community Consensus Trade Alerts - Newser
What machine learning models say about Bausch + Lomb CorporationProduct Launch & Reliable Price Action Trade Plans - Newser
Is now a turning point for Bausch + Lomb CorporationMarket Activity Report & Real-Time Stock Price Movement Reports - Newser
How hedge fund analytics apply to Bausch + Lomb Corporation stockWeekly Volume Report & Daily Price Action Insights - Newser
Stable Stocks to Watch: Hudson Technologies and Bausch + Lomb Underperform, Intuit Shines - AInvest
Bausch + Lomb to Participate in Upcoming September 2025 Investor Conferences - BioSpace
Eye Care Leader Bausch + Lomb Leadership to Share Strategic Updates at JPM and Morgan Stanley Events - Stock Titan
Bausch + Lomb to Participate in Upcoming Investor Conferences - Yahoo Finance
Bausch + Lomb’s SWOT analysis: ophthalmology leader faces spin-off uncertainty - Investing.com
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know - Yahoo Finance
How Bausch + Lomb Corporation stock performs during market volatilityLow Float Big Mover Alerts - thegnnews.com
TR | OpenAI4o Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $14 - 富途牛牛
BofA Securities Maintains Bausch + Lomb Corp.(BLCO.US) With Sell Rating, Raises Target Price to $13 - 富途牛牛
Bausch + Lomb (NYSE:BLCO) Price Target Raised to $13.00 - Defense World
Is it the right time to buy Bausch + Lomb Corporation stockMaximize gains with proven stock analysis - Jammu Links News
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2025 Earnings Call Transcript - Insider Monkey
Bausch + Lomb Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Bausch & Lomb Raises Price Target to $16.00 Amid Positive Analyst Sentiment. - AInvest
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Bausch + Lomb:HC Wainwright Raises PT to $16, Maintains Buy Rating - AInvest
Bausch & Lomb Corp (BLCO) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Challenges By GuruFocus - Investing.com Canada
Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering - 富途牛牛
Bausch & Lomb Corp SEC 10-Q Report - TradingView
Bausch + Lomb Q2 Adjusted Income Lower, Revenue Increases - 富途牛牛
Earnings call transcript: Bausch + Lomb Q2 2025 beats earnings expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Bausch + Lomb Q2 2025 beats earnings expectations - Investing.com
Bausch + Lomb Lifts Outlook After Beating Revenue Expectations - Finimize
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Bausch + Lomb Announces Second-Quarter 2025 Results - BioSpace
Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates - ca.finance.yahoo.com
Bausch + Lomb: Q2 Earnings Snapshot - San Antonio Express-News
Bausch + Lomb’s (NYSE:BLCO) Q2 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Bausch + Lomb Q2 2025 slides: Revenue growth accelerates, guidance raised - Investing.com Australia
Bausch + Lomb Q2 2025 slides: Revenue growth accelerates, guidance raised By Investing.com - Investing.com South Africa
Bausch + Lomb tops Q2 expectations, raises full-year guidance By Investing.com - Investing.com Canada
Bausch + Lomb tops Q2 expectations, raises full-year guidance - Investing.com
Bausch + Lomb Q2 2025 Financial Results - TradingView
Examining the Future: Bausch & Lomb's Earnings Outlook - 富途牛牛
Bausch + Lomb Corporation Breaks Below Key Support LevelLow Volatility Stable Growth Picks Rank High - beatles.ru
Stocks In Play: Bausch + Lomb Corporation - Barchart.com
Bausch & Lomb Corp (TSX:BLCO) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops - Stock Titan
Bausch + Lomb Corp expected to post earnings of 7 cents a shareEarnings Preview - TradingView
Bausch + Lomb (BLCO) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
What are analysts’ price targets for Bausch + Lomb Corporation in the next 12 monthsIdentify breakout stocks before they peak - Jammu Links News
Bausch + Lomb Maintained at Outperform at RBC Ahead of Q2 Results; Price Target Kept at US$17.00 - 富途牛牛
What analysts say about Bausch + Lomb Corporation stockFree Trend-Following Techniques - Autocar Professional
6.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):